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Introduction
In recent years, epoxide hydrolases (EHs) (EC 3.3.2.3) have been shown to be ubiquitous in nature, to be cofactor independent and to catalyze the enantioselective addition of water to an epoxide, thus leading to the corresponding diol and the recovery of the less reactive substrate enantiomer via a biocatalysed hydrolytic kinetic resolution (BHKR). 1±7 One general advantage of this approach is the fact that it constitutes a typical`green chemistry' process, which can be run using water as the only solvent and reactant, and only implies a natural and biodegradable catalyst, i.e. an enzyme. Using such a strategy, both the epoxide and the diol can be obtained inÐideallyÐenantiopure form. Moreover, since this process is a kinetic resolution, it is generally possible to tune the ee of the remaining epoxide up to enantiopurity, simply by choosing the appropriate extent of conversion. Furthermore, combination of enantioand regiocomplementary enzymes can, in certain cases, enable to develop highly valuable enantioconvergent processes allowing to overcome the 50% yield limitation intrinsic to a common resolution process. We have for instance recently illustrated the possible use of a fungal epoxide hydrolase for the synthesis of enantiomerically pure bioactive compounds like Ibuprofen 8 or Eliprodil. 9 This method may be even more attractive if it allows the preparation of epoxides which cannot be obtained by using the presently available conventional chemistry approaches. This is for instance the case for 2-, 3-and 4-pyridyloxirane 1±3, 10 which are key-step building blocks for the synthesis of several biologically active compounds, such as b-adrenergic receptor antagonists or anti-obesity drugs. 11±13 We have recently shown that these substrates can be conveniently obtained in enantiopure form using partially puri®ed EH from Aspergillus niger, 14 and were interested in testing other enzymes in this context. In particular, some of us have recently isolated, cloned and overexpressed the epoxide hydrolase from the bacterium Agrobacterium radiobacter AD1 and studied some of its enzyme/substrate properties.
15±18 Both the A. niger and the A. radiobacter EHs have recently been crystallized and their three-dimensional structure has been determined. 19, 20 Moreover, a Tyr215Phe mutant of the A. radiobacter enzyme has been constructed and was shown to exhibit a substantial improvement of the enantioselectivity (E value) for (substituted) styrene oxides. 17 The experiments described here were aimed at obtaining kinetic resolution of 1±3 (Scheme 1) using the wild type A. radiobacter epoxide hydrolase (ArWT) and its Tyr215Phe mutant.
Results and discussion

Resolution of pyridyloxiranes by wild-type and mutant A. radiobacter epoxide hydrolase
Previous work has shown that the A. radiobacter epoxide hydrolase was able to hydrolyze styrene oxide and various derivatives thereof. 15 One of the most intriguing facts is the existence of a so-called`sequential' mechanism. Thus, owing to the fact that the K M ratio of the two enantiomers is very high (K M (S)/K M (R)46), hydrolysis of the (S)-enantiomer is almost completely inhibited by the (R)-enantiomer as long as the latter has not totally disappeared. After consumption of the (R)-enantiomer, the (S)-enantiomer is consumed much faster, due to the fact that its k cat value is higher than that of the (R) enantiomer (k cat (S)/k cat (R)2.5). This is evidently an important drawback for the use of such a catalyst at a preparative scale, since it necessitates to very accurately tune the extent of conversion of such a BHKR in order to obtain a reasonable ee/yield compromise. Surprisingly enough, this is no more the case for the mutated enzyme, where a classical kinetic pro®le implying a consistent rate difference between the two enantiomers was observed. 17, 21 A similar reaction pro®le was similarly observed for compounds 1±3 (Fig. 1) . Thus, the ArWT EH again showed a sequential mechanism for all three substrates, while the Tyr215Phe EH clearly hydrolyzed one enantiomer much slower than the other one, even after consumption of the preferred enantiomer. 22 This difference in behavior is illustrated by Fig. 1 in the case of epoxide 1. For both enzymes, the remaining antipode was of (S)-con®guration. At 7 mM substrate concentration, we observed as expected a signi®cant increase in enantioselectivity for the mutated EH (Table 1) .
Enantio-and regioselectivity determination
Due to the possible combination of enantio-and regioselectivity inherent to epoxide hydrolase catalyzed resolutions, 23 the E-values corresponding to the various experiments were calculated on the basis of the ee of the remaining substrate and the degree of conversion ( Table 1) . As expected, the mutated enzyme exhibited a higher enantioselectivity then the wild type enzyme towards substrates 1±3. This clearly con®rms that replacement of the active site Tyr215 residue by a phenylalanine constitutes an important factor for enhancing the overall enantioselectivity of this epoxide hydrolase for structurally different substrates.
An epoxide can a priori be attacked at either carbon atom of the oxirane ring. We therefore determined the a (S)/b (S) and a (R)/b (R) ratio for 1±3, using the ee of the diol obtained upon biohydrolysis of the enantiopure (S)-epoxide and the ee of the diol formed after total conversion of the racemic epoxide. 23 The results obtained for the EH of ArWT and the Tyr215Phe mutant are summarized in Table 2 . No difference of regioselectivity could be observed between the wild type and the mutant enzyme, both enzymes showing a highly preferential attack at the b-carbon atom in all cases. Since for all three substrates the a (S) and a (R) values were identical for both enantiomers, racemic diol was formed upon completion of the reaction (ee f 0%). However, as also observed for the A. niger EH, 14 the regioselectivity was found to be a function of the position of the nitrogen atom and showed a slight increase of the a=b ratio 1 to 3. Thus, the best regioselectivity was observed for 1, with only 3% of the attack occurring at the a position.
Inhibition by the diol
Product inhibition can be a serious problem for scaling up kinetic resolutions. If the product formed is a strong competitive inhibitor, the conversion rate will slow down during Figure 1 . BHKR of 1 (7 mM, 288C, 500 rpm) using the A. radiobacter wild type enzyme (ArWT) (0.02 g/L) or the Tyr215Phe mutant EHs (0.34 g/L). The spontaneous hydrolysis of 1 at 288C was estimated to be about 0.005%/ min. Therefore, the E-values given in this table are apparent values, and the actual enzyme enantioselectivity must be somewhat higher.
progress of the reaction and thus limit a large-scale conversion. Inhibition of the activity of Tyr215Phe mutant EH by diol 1d was determined by investigating its effect on the conversion of (R)-para-nitrostyrene oxide. The obtained K i was 122 mM. One should note that these experiments were performed using racemic 1d, which implies that the strongest inhibiting enantiomer could have an up to twofold lower K i value. This implies that, for a kinetic resolution with, for example, a starting concentration of 122 mM, the apparent k cat /K M is still at 50% or higher when the preferred enantiomer is completely converted.
Activity at high substrate levels
Another limiting factor we have previously observed for scaling up some EH-mediated resolutions was the solubility of the substrate in the reaction medium (aqueous buffer). If the substrate concentration exceeds its solubility, an emulsion is formed which can quickly inactivate the enzyme. 21 Interestingly, substrates 1±3 exhibit much higher solubilities in water (i.e. 1: 454 mM (55 g/L) at 288C) than styrene oxide derivatives, which should avoid this limitation. As 1 showed the best enantioselectivity with both EHs, it was used to explore the possibility to achieve conversion at high substrate concentration. Using the ArWT EH, a substrate concentration as high as 200 mM (24.3 g/L) still led to an excellent ee (ee .99%, c58%, 1 h reaction) of the remaining epoxide 1 after a reaction time of about 70 min (288C) indicating that product inhibition was still not predominant. At higher concentration however, enzyme inhibition clearly occurred, thus slowing down the reaction and affording the remaining substrate in only very low ee (ee7%, c<12%, 6 h reaction, 250 mM). Using the Tyr215Phe EH, the substrate concentration limit was even slightly higher, a 95% ee being obtained at 300 mM (36.3 g/L) (c56%, 7 h reaction). Higher concentration again led to enzyme inhibition. It is interesting to emphasize the fact that, in contrast to what we observed with the A. niger EH, 14 the E-value remained constant for both enzymes upon increase of substrate concentration.
Preparative scale conversion
Based on these results, a preparative scale conversion of 1 using both A. radiobacter EHs was carried out at a concentration of 127 mM (Scheme 2). The reaction was stopped when the ee of the residual epoxide reached a value of about 98%, as a good compromise between ee and overall yield. Enantiomerically pure 1 could of course be obtained by leaving the reaction proceed for some additional time.
In a typical experiment, 2 g (16.5 mmol) of rac-1 was submitted to a BHKR procedure using 9 mg of a partially puri®ed enzyme extract of ArWT (speci®c activity for 1: 13 U/mg protein). The corresponding concentrations were, respectively, 15.4 g/L (127 mM) of substrate and 0.07 g/L of enzyme extract. The reaction was carried out at 288C in 130 mL phosphate buffer. After 160 min, usual work-up led to 0.69 g (34.5% puri®ed yield) of (S)-1Ðwhich showed an ee of .99% and 1.3 g (R)-1d (56.6% puri®ed yield) with an ee of 71%. The calculated turnover number (TON) was estimated to be about 13,200 mol substrate/mol enzyme/h and the space time yield was about 48 g/L/day.
Similarly, a preparative scale BHKR was carried out using the Tyr215Phe EH. Thus, 2 g (16.5 mmol) of rac-1 was hydrolyzed using a solution of 128 mg (15.4 mL) of a partially puri®ed enzyme extract (speci®c activity for 1: 0.11 U/mg protein) at 288C in 130 mL phosphate buffer. The corresponding concentrations were respectively 15.4 g/L (127 mM) of substrate and 0.98 g/L enzyme extract. After 7 h and usual work-up, this led to 0.72 g (36% puri®ed yield) of (S)-1 which showed an ee of 98% and 0.925 g of (R)-1d (40% puri®ed yield) with an ee of 81%. These ee values were determined using chiral GC analysis as described in the experimental part. The calculated turnover number (TON) was estimated to be about 360 mol substrate/mol enzyme/h and the space time yield was about 19 g/L/day. It is to be emphasized that, in our hands, neither of the conventional chemistry approaches known to date (i.e. the Table 2 . Regioselectivity for the hydrolysis of 1±3 using the ArWT epoxide hydrolase and its Tyr215Phe mutant heavy metal-based Jacobsen epoxidation or HKR strategy) were effective under standard experimental conditions for the preparation of enantiopure 1±3. 14 This is probably due to the low reactivity of the corresponding ole®n and/or to a complexation (or reaction) of the pyridine substrate with the metal catalyst (or reagents).
Conclusions
The results we have obtained throughout this work indicate that substrates 1±3 were ef®ciently and enantioselectively hydrolyzed using the wild-type epoxide hydrolase from the bacteria A. radiobacter as well as by its Tyr215Phe mutant. The wild type enzyme clearly showed a so-called sequential mechanism for all three epoxides, as already observed with other substrates, while in contrast the Tyr215Phe mutant exhibited a classical kinetic pro®le. These results show that the active-site mutation introduced into the Agrobacterium enzyme on basis of the X-ray structure has yielded a more suitable catalyst for various kinetic resolutions, making the enzyme more versatile. Since Tyr215 is conserved in other epoxide hydrolase sequences, it is well conceivable that the same mutation can also be used to improve the applicability of other epoxide hydrolases.
The enantio-and regioselectivity of these BHKR were determined. As expected from previous observations, the mutant enzyme exhibited a slight increase in enantioselectivity and both enzymes showed the same regioselectivity. Interestingly, in contrast to the previously observed results using the same enzymes but different substrates, 2-pyridyloxirane 1 could be operated at concentrations as high as 200 mM for the wild-type epoxide hydrolase and up to 300 mM for the mutant enzyme. These were used to achieve a preparative scale synthesis of enantiopure (S)-1 (ee.99%) at a 127 mM (15.4 g/L) concentration. Due to the fact that conventional chemistry approaches, including the Jacobsen HKR cobalt-based catalyst, were not successful in our hands, these results, together with those obtained using the Aspergillus niger epoxide hydrolase, are particularly interesting from the`chirotechnology' point of view. Work is in progress in our laboratories in order to widen the scope of this epoxide hydrolase based green chemistry technology.
Experimental
General
For gas chromatographic analysis, the chiral columns Chiralsil Dex CB (Chrompack) and Lipodex E (Macherey and Nagel) were used. This allowed to determine the ee of 1±3. The enzyme solutions were prepared as described by Rink et al. 16 The synthesis of 1±3 and 1d±3d have been described. 14 4.1.1. Determination of the ee of 2-pyridyldiol 1d by derivatisation to the dimethylether. The ee was determined by adding 100 mL DMSO, KOH and 12 mL iodomethane to the dry diol. This was stirred for 30 min at RT. The formed dimethylether was extracted with diethylether and analyzed by GC (col. Lipodex E, 908C; 23 and 25 min). The aqueous phase was then lyophilized, and 1d was directly extracted with acetone from the resulting dry diolsalt and puri®ed by¯ash chromatography. From the CHCl 3 phase the epoxide and the diol were puri®ed by¯ash chromatography: epoxide: pentane/ethylacetate 4/6; diol: ethylacetate/methanol: 9/1. The fractions containing the epoxide and respectively the diol were pooled, dried over Na 2 SO 4 , and the solvent was removed by stripping. The fractions containing the diol were treated similarly. The epoxide was further puri®ed by bulb-to-bulb distillation (4£10 22 mbar, 408C).
